Analysis-Launch of arthritis drug biosimilars ramps up US pr

Cheaper versions of one of the most costly and widely used arthritis treatments in the U.S. are likely to fuel further scrutiny of the middlemen that negotiate drug prices for most insured...

Related Keywords

New York , United States , Washington , San Francisco , California , Novarti Sandoz , Patrick Wingrove , Moira Warburton , Robin Feldman , Caroline Humer , Josephine Walker , Ron Wyden , Chuck Grassley , Cigna Group Express Scripts , Amgen , Reuters , Health Caremark , Unitedhealth Group Optum , University California College Of The Law , Biosimilars Forum , Harvard Medical School , Association For Accessible Medicines , Accessible Medicines , Ameet Sarpatwari , Harvard Medical , Inflation Reduction Act , Federal Trade Commission , Cigna Group , Express Scripts , Unitedhealth Group , University California College , Democratic Senator Ron Wyden , Republican Senator Chuck Grassley , Bill Berkrot , Markets ,